U O Barbosa

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Treatment of chronic hepatitis C is still unspecific. However, there is great expectancy concerning the new pegylated interferons. As there has been much controversy about the best parameters to determine whether treatment is effective, we analyzed several criteria currently used for evaluation, including serum alanine aminotransferase (ALT) normalization,(More)
  • 1